Total Payments
$213.71
2024 Payments
$140.60
Companies
7
Transactions
8
Medicare Patients
3,476
Medicare Billing
$553,330
Payment Breakdown by Category
Food & Beverage$213.71 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $213.71 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $80.70 | 1 | $0 (2024) |
| Ethicon US, LLC | $42.60 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.10 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18.41 | 1 | $0 (2018) |
| Covidien LP | $13.37 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.82 | 1 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $12.71 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140.60 | 3 | Medtronic, Inc. ($80.70) |
| 2023 | $28.62 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($15.80) |
| 2021 | $12.71 | 1 | BOSTON SCIENTIFIC CORPORATION ($12.71) |
| 2018 | $31.78 | 2 | Janssen Pharmaceuticals, Inc ($18.41) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Ethicon US, LLC | Harmonic (Device) | Food and Beverage | In-kind items and services | $42.60 | General |
| Category: Energy | ||||||
| 04/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/29/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $80.70 | General |
| Category: Gastrointestinal AI | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Gastroenterology | ||||||
| 10/28/2021 | BOSTON SCIENTIFIC CORPORATION | RESOLUTION CLIP (Device) | Food and Beverage | Cash or cash equivalent | $12.71 | General |
| Category: Resolution Clip | ||||||
| 12/04/2018 | Covidien LP | HET (Device) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Vessel Sealing | ||||||
| 08/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 979 | 1,144 | $565,725 | $161,421 |
| 2022 | 8 | 492 | 534 | $281,150 | $79,986 |
| 2021 | 14 | 1,121 | 1,313 | $646,900 | $187,731 |
| 2020 | 12 | 884 | 1,010 | $519,400 | $124,192 |
Total Patients
3,476
Total Services
4,001
Medicare Billing
$553,330
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46500 | Injection of hemorrhoid | Office | 2023 | 61 | 112 | $44,800 | $30,181 | 67.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 295 | 295 | $59,000 | $24,366 | 41.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 42 | 94 | $47,000 | $22,714 | 48.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 106 | 107 | $128,400 | $20,264 | 15.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 89 | 89 | $133,500 | $18,414 | 13.8% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Office | 2023 | 97 | 104 | $36,400 | $14,304 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 143 | $21,450 | $10,169 | 47.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 35 | 35 | $42,000 | $6,688 | 15.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $25,200 | $2,932 | 11.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 37 | $7,400 | $2,456 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 54 | $6,750 | $2,454 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,750 | $2,438 | 51.3% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 20 | 21 | $4,200 | $2,148 | 51.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $4,875 | $1,892 | 38.8% |
| 46500 | Injection of hemorrhoid | Office | 2022 | 41 | 61 | $24,400 | $17,353 | 71.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 74 | 74 | $88,800 | $14,545 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 172 | 172 | $34,400 | $14,199 | 41.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 39 | $58,500 | $8,195 | 14.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 23 | 31 | $15,500 | $7,687 | 49.6% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Office | 2022 | 49 | 54 | $18,900 | $7,585 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 79 | $11,850 | $5,706 | 48.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 24 | 24 | $28,800 | $4,717 | 16.4% |
| 46500 | Injection of hemorrhoids | Office | 2021 | 56 | 112 | $43,600 | $31,091 | 71.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 337 | 337 | $66,890 | $28,509 | 42.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2021 | 48 | 113 | $56,250 | $28,195 | 50.1% |
About Dr. Steven Harper, MD
Dr. Steven Harper, MD is a Colon & Rectal Surgery healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609865401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Harper, MD has received a total of $213.71 in payments from pharmaceutical and medical device companies, with $140.60 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($213.71).
As a Medicare-enrolled provider, Harper has provided services to 3,476 Medicare beneficiaries, totaling 4,001 services with total Medicare billing of $553,330. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location Abington, PA
- Active Since 10/14/2005
- Last Updated 07/12/2010
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1609865401
Products in Payments
- GI GENIUS (Device) $80.70
- Harmonic (Device) $42.60
- GATTEX (Drug) $33.10
- XARELTO (Drug) $18.41
- HET (Device) $13.37
- XIFAXAN (Drug) $12.82
- RESOLUTION CLIP (Device) $12.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.